Literature DB >> 26934047

Does comorbid anxiety counteract emotion recognition deficits in conduct disorder?

Roxanna M L Short1, Edmund J S Sonuga-Barke1,2, Wendy J Adams1, Graeme Fairchild1.   

Abstract

BACKGROUND: Previous research has reported altered emotion recognition in both conduct disorder (CD) and anxiety disorders (ADs) - but these effects appear to be of different kinds. Adolescents with CD often show a generalised pattern of deficits, while those with ADs show hypersensitivity to specific negative emotions. Although these conditions often cooccur, little is known regarding emotion recognition performance in comorbid CD+ADs. Here, we test the hypothesis that in the comorbid case, anxiety-related emotion hypersensitivity counteracts the emotion recognition deficits typically observed in CD.
METHOD: We compared facial emotion recognition across four groups of adolescents aged 12-18 years: those with CD alone (n = 28), ADs alone (n = 23), cooccurring CD+ADs (n = 20) and typically developing controls (n = 28). The emotion recognition task we used systematically manipulated the emotional intensity of facial expressions as well as fixation location (eye, nose or mouth region).
RESULTS: Conduct disorder was associated with a generalised impairment in emotion recognition; however, this may have been modulated by group differences in IQ. AD was associated with increased sensitivity to low-intensity happiness, disgust and sadness. In general, the comorbid CD+ADs group performed similarly to typically developing controls.
CONCLUSIONS: Although CD alone was associated with emotion recognition impairments, ADs and comorbid CD+ADs were associated with normal or enhanced emotion recognition performance. The presence of comorbid ADs appeared to counteract the effects of CD, suggesting a potentially protective role, although future research should examine the contribution of IQ and gender to these effects.
© 2016 Association for Child and Adolescent Mental Health.

Entities:  

Keywords:  Conduct disorder; anxiety disorder; callous-unemotional traits; comorbidity; emotion recognition; response biases; social information processing

Mesh:

Year:  2016        PMID: 26934047     DOI: 10.1111/jcpp.12544

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  6 in total

1.  Psychopathic traits are associated with reduced fixations to the eye region of fearful faces.

Authors:  Monika Dargis; Richard C Wolf; Michael Koenigs
Journal:  J Abnorm Psychol       Date:  2018-01

2.  Impaired social cognition in violent offenders: perceptual deficit or cognitive bias?

Authors:  Aiste Jusyte; Michael Schönenberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-09-13       Impact factor: 5.270

3.  Externalizing Behaviors and Callous-Unemotional Traits: Different Associations With Sleep Quality.

Authors:  Dan Denis; Reece Akhtar; Benjamin C Holding; Christina Murray; Jennifer Panatti; Gordon Claridge; Avi Sadeh; Nicola L Barclay; Rachael O'Leary; Barbara Maughan; Tom A McAdams; Richard Rowe; Thalia C Eley; Essi Viding; Alice M Gregory
Journal:  Sleep       Date:  2017-08-01       Impact factor: 5.849

4.  Empathic Accuracy in Male Adolescents with Conduct Disorder and Higher versus Lower Levels of Callous-Unemotional Traits.

Authors:  N Martin-Key; T Brown; G Fairchild
Journal:  J Abnorm Child Psychol       Date:  2017-10

5.  In the eyes of the beholder: investigating the effect of visual probing on accuracy and gaze fixations when attending to facial expressions among primary and secondary callous-unemotional variants.

Authors:  Melina Nicole Kyranides; Kostas A Fanti; Maria Petridou; Eva R Kimonis
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-12-06       Impact factor: 4.785

6.  Pediatric anxiety associated with altered facial emotion recognition.

Authors:  Lance M Rappaport; Nicole Di Nardo; Melissa A Brotman; Daniel S Pine; Ellen Leibenluft; Roxann Roberson-Nay; John M Hettema
Journal:  J Anxiety Disord       Date:  2021-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.